rs2072246

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001617.4(ADD2):​c.556-497G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.29 in 151,910 control chromosomes in the GnomAD database, including 6,731 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 6731 hom., cov: 31)

Consequence

ADD2
NM_001617.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.302

Publications

3 publications found
Variant links:
Genes affected
ADD2 (HGNC:244): (adducin 2) Adducins are heteromeric proteins composed of different subunits referred to as adducin alpha, beta and gamma. The three subunits are encoded by distinct genes and belong to a family of membrane skeletal proteins involved in the assembly of spectrin-actin network in erythrocytes and at sites of cell-cell contact in epithelial tissues. While adducins alpha and gamma are ubiquitously expressed, the expression of adducin beta is restricted to brain and hematopoietic tissues. Adducin, originally purified from human erythrocytes, was found to be a heterodimer of adducins alpha and beta. Polymorphisms resulting in amino acid substitutions in these two subunits have been associated with the regulation of blood pressure in an animal model of hypertension. Heterodimers consisting of alpha and gamma subunits have also been described. Structurally, each subunit is comprised of two distinct domains. The amino-terminal region is protease resistant and globular in shape, while the carboxy-terminal region is protease sensitive. The latter contains multiple phosphorylation sites for protein kinase C, the binding site for calmodulin, and is required for association with spectrin and actin. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jun 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.423 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001617.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADD2
NM_001617.4
MANE Select
c.556-497G>A
intron
N/ANP_001608.1P35612-1
ADD2
NM_001185054.2
c.556-497G>A
intron
N/ANP_001171983.1P35612-1
ADD2
NM_017488.4
c.556-497G>A
intron
N/ANP_059522.1P35612-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADD2
ENST00000264436.9
TSL:1 MANE Select
c.556-497G>A
intron
N/AENSP00000264436.3P35612-1
ADD2
ENST00000407644.6
TSL:1
c.556-497G>A
intron
N/AENSP00000384677.2P35612-1
ADD2
ENST00000355733.7
TSL:1
c.556-497G>A
intron
N/AENSP00000347972.3P35612-3

Frequencies

GnomAD3 genomes
AF:
0.290
AC:
43988
AN:
151792
Hom.:
6722
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.384
Gnomad AMI
AF:
0.238
Gnomad AMR
AF:
0.254
Gnomad ASJ
AF:
0.219
Gnomad EAS
AF:
0.437
Gnomad SAS
AF:
0.322
Gnomad FIN
AF:
0.242
Gnomad MID
AF:
0.304
Gnomad NFE
AF:
0.240
Gnomad OTH
AF:
0.267
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.290
AC:
44061
AN:
151910
Hom.:
6731
Cov.:
31
AF XY:
0.291
AC XY:
21582
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.384
AC:
15882
AN:
41388
American (AMR)
AF:
0.254
AC:
3886
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.219
AC:
761
AN:
3470
East Asian (EAS)
AF:
0.438
AC:
2259
AN:
5162
South Asian (SAS)
AF:
0.323
AC:
1555
AN:
4810
European-Finnish (FIN)
AF:
0.242
AC:
2563
AN:
10574
Middle Eastern (MID)
AF:
0.286
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
0.240
AC:
16286
AN:
67926
Other (OTH)
AF:
0.270
AC:
568
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1557
3114
4670
6227
7784
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
458
916
1374
1832
2290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.265
Hom.:
685
Bravo
AF:
0.296
Asia WGS
AF:
0.377
AC:
1308
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
2.9
DANN
Benign
0.25
PhyloP100
-0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2072246; hg19: chr2-70920181; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.